enVVeno Medical (NVNO) Research & Development (2017 - 2026)
enVVeno Medical's quarterly Research & Development came in at $2.1 million in Q1 2026, down 17.44% year-on-year from $2.6 million in Q1 2025, and up 8.37% quarter-over-quarter from $1.9 million in Q4 2025.
enVVeno Medical has reported Research & Development for 10 years, with the latest figure at $2.1 million in Q1 2026.
- For the quarter ending Q1 2026, Research & Development fell 17.44% year-over-year to $2.1 million; the trailing twelve-month figure through Mar 2026 stood at $9.5 million (down 18.88% YoY), and the FY2025 full-year result was $10.0 million, down 18.52% from the prior year.
- Research & Development for Q1 2026 stood at $2.1 million, up from $1.9 million in the prior quarter.
- The five-year high for Research & Development was $4.2 million in Q2 2023, with the low at $1.6 million in Q1 2022.
- Average Research & Development over 5 years is $2.8 million, with a median of $2.8 million recorded in 2024.
- Year-over-year, Research & Development surged 181.93% in 2022 and slumped 44.55% in 2025.
- Tracing NVNO's Research & Development over 5 years: stood at $2.8 million in 2022, then rose by 6.58% to $3.0 million in 2023, then rose by 17.85% to $3.5 million in 2024, then tumbled by 44.55% to $1.9 million in 2025, then gained by 8.37% to $2.1 million in 2026.
- The last three Research & Development figures came in at $2.1 million (Q1 2026), $1.9 million (Q4 2025), and $2.6 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 767.00 Mn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 413.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 722.00 Mn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 516.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 263.30 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -461.27 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 145.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 345.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 28.80 Mn |
| 10 | enVVeno Medical | 6.99 Mn | 6.99 Mn | - | 2.11 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.11 Mn |
| Dec 31, 2025 | 1.95 Mn |
| Sep 30, 2025 | 2.59 Mn |
| Jun 30, 2025 | 2.89 Mn |
| Mar 31, 2025 | 2.56 Mn |
| Dec 31, 2024 | 3.51 Mn |
| Sep 30, 2024 | 2.86 Mn |
| Jun 30, 2024 | 2.83 Mn |
| Mar 31, 2024 | 3.05 Mn |
| Dec 31, 2023 | 2.98 Mn |
| Sep 30, 2023 | 2.80 Mn |
| Jun 30, 2023 | 4.21 Mn |
| Mar 31, 2023 | 3.60 Mn |
| Dec 31, 2022 | 2.80 Mn |
| Sep 30, 2022 | 2.49 Mn |
| Jun 30, 2022 | 3.07 Mn |
| Mar 31, 2022 | 1.55 Mn |
| Dec 31, 2021 | 1.78 Mn |
| Sep 30, 2021 | 1.23 Mn |
| Jun 30, 2021 | 1.09 Mn |
| Mar 31, 2021 | 1.63 Mn |
| Dec 31, 2020 | 2.28 Mn |
| Sep 30, 2020 | 758,198.00 |
| Jun 30, 2020 | 706,173.00 |
| Mar 31, 2020 | 510,624.00 |
| Dec 31, 2019 | 787,827.00 |
| Sep 30, 2019 | 676,970.00 |
| Jun 30, 2019 | 428,309.00 |
| Mar 31, 2019 | 313,013.00 |
| Dec 31, 2018 | 293,241.00 |
| Sep 30, 2018 | 424,596.00 |
| Jun 30, 2018 | 280,419.00 |
| Mar 31, 2018 | 240,493.00 |
| Dec 31, 2017 | 349,088.00 |
| Sep 30, 2017 | 43,069.00 |
| Jun 30, 2017 | 184,919.00 |